ImmuneTarget, Inc.
4Patents
4Active
4Granted
43Portfolio score
Filing activity: Dec 29, 2016 → Apr 27, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10226464B2 | Small molecule NF-κB inhibitors | Human Necessities | 1 | Active |
| US11083729B2 | Methods of treating cancer with small molecule NF-κB inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11266648B2 | Substituted chromeno[2,3-d]pyrimidines as NF-κB inhibitors | Human Necessities | 0 | Active |
| US10660894B2 | Small molecule NF-κB inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.